MOESM1 of Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study

Additional file 1: Table S1. P-values of comparisons of baseline clinical characteristics in eyes with polypoidal choroidal vasculopathy performed three different regimens, including anti-VEGF monotherapy, initial combination therapy, and deferred combination therapy.